Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).

Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV; Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.

2.

Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).

Murphy TV, Slade BA, Broder KR, Kretsinger K, Tiwari T, Joyce PM, Iskander JK, Brown K, Moran JS; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2008 May 30;57(RR-4):1-51. Review. Erratum in: MMWR Morb Mortal Wkly Rep. 2008 Jul 4;57(26):723.

3.
6.

Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.

Gidengil CA, Sandora TJ, Lee GM.

Expert Rev Vaccines. 2008 Jul;7(5):621-34. doi: 10.1586/14760584.7.5.621. Review.

PMID:
18564017
9.

Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.

Bechini A, Tiscione E, Boccalini S, Levi M, Bonanni P.

Vaccine. 2012 Jul 27;30(35):5179-90. doi: 10.1016/j.vaccine.2012.06.005. Epub 2012 Jun 15. Review.

PMID:
22709953
10.

Acellular pertussis vaccine for adolescents.

de Carvalho AP, Pereira EM.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S15-24. Epub 2006 Jun 16. Review.

11.

An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine.

Pichichero ME, DeTora LM, Johnson DR.

Expert Rev Vaccines. 2006 Apr;5(2):175-87. Review.

PMID:
16608418
12.

Shortened interval between tetanus vaccines.

Lodolce AE.

Ann Pharmacother. 2012 Jun;46(6):884-8. doi: 10.1345/aph.1Q651. Epub 2012 Jun 5. Review.

PMID:
22669800
13.

Prevention of pertussis through adult vaccination.

Suryadevara M, Domachowske JB.

Hum Vaccin Immunother. 2015;11(7):1744-7. doi: 10.1080/21645515.2015.1038442. Review.

14.

New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).

Johns TL, Hutter GE.

Ann Pharmacother. 2010 Mar;44(3):515-23. doi: 10.1345/aph.1M468. Review.

PMID:
20197476
15.

Protecting Newborns Against Pertussis: Treatment and Prevention Strategies.

Salim AM, Liang Y, Kilgore PE.

Paediatr Drugs. 2015 Dec;17(6):425-41. doi: 10.1007/s40272-015-0149-x. Review.

PMID:
26542059
18.

Pertussis immunisation in adolescents and adults.

Heininger U.

Adv Exp Med Biol. 2008;609:72-97. doi: 10.1007/978-0-387-73960-1_7. Review.

PMID:
18193659
19.

Acellular pertussis vaccine safety and efficacy in children, adolescents and adults.

Casey JR, Pichichero ME.

Drugs. 2005;65(10):1367-89. Review.

PMID:
15977969
20.

Reduced-antigen combined diphtheria-tetanus-acellular pertussis vaccine (Boostrix).

Chapman TM, Goa KL.

Drugs. 2003;63(13):1407-13; discussion: 1415-6. Review.

PMID:
12825963

Supplemental Content

Support Center